Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SANTA MONICA, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced the Compensation Committee of the Company’s Board of Directors has approved the grant of restricted stock units (“RSU”) covering an...

Click to view original post